Bharat Biotech is targeting one billion doses in annual production. This is from its own sites alone, reports Sohini Das. India’s first indigenous Covid-19 vaccine to be approved, Bharat......
While Covishield supplies would meet the target of 500 mn doses between August and December, it looks like Covaxin would miss the target of 400 mn unless the partner sites of Bharat Biotech ramp up......
To address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously......
This apart, to further increase capacities, Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for Covaxin. The technology transfer process is......
India is expecting 156 million doses of the vaccine from August to September, reports Ruchika Chitravanshi. Photograph: Kind courtesy Russian Direct Investment Fund on Facebook Sputnik V, the......
An agreement to set up an Indian technology centre in Moscow to promote commercial use of Russian technology will be signed during Science and Technology Minister Kapil Sibal's visit beginning......